In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

The experiences of women with a subcutaneous implantable cardioverter defibrillator

Session Top of the pops in arrhythmia treatment - from life-style modification to lead extraction

Speaker Willeke van der Stuijt

Event : ESC Congress 2019

  • Topic : arrhythmias and device therapy
  • Sub-topic : Implantable Cardioverter / Defibrillator
  • Session type : Abstract Sessions

Authors : W Van Der Stuijt (Amsterdam,NL), ABE Quast (Amsterdam,NL), SWE Baalman (Amsterdam,NL), AAM Wilde (Amsterdam,NL), RE Knops (Amsterdam,NL)

W. Van Der Stuijt1 , A.B.E. Quast1 , S.W.E. Baalman1 , A.A.M. Wilde1 , R.E. Knops1 , 1Academic Medical Center of Amsterdam, Cardiology - Amsterdam - Netherlands (The) ,

Implantable Cardioverter / Defibrillator

European Heart Journal ( 2019 ) 40 ( Supplement ), 3651

Introduction: The subcutaneous implantable cardioverter defibrillator (S-ICD) is positioned in close proximity of the left mamma. In female patients, this may result in issues, such as limitations in clothing, breastfeeding or self-perception. Moreover, female patients are underrepresented in most large S-ICD studies, thus underexposing these gender-specific issues which may impact their daily life substantially.

Objective: To assess the issues female S-ICD patients are experiencing and provide practical “tips and tricks” for cardiologists and implanters to minimalize gender-specific issues.

Methods: All female patients implanted with an S-ICD in a large tertiary center between February 2009 and November 2018 received a single questionnaire with questions on physical, esthetical and situational issues.

Results: Patients were categorized in three age groups, 18–39 years (n=32), 40–55 years (n=35) and >55 years (n=19). Eighty-four percent of the patients experienced pain after S-ICD implant, almost half (42.9%) of those patients reported extreme pain. After S-ICD implant, self-perception was altered in a small group (20%) and a third of the patients does not wear the same clothing as before. During sexual activity, many female patients actively avoid the touch of their partner on the lead and generator due to discomfort. While no-one reported problems with childbirth or breastfeeding, two patients did experience irritation from the lead during their pregnancies, possibly due to growth of the mammae. The majority of patients (64%) experiences daily discomfort while wearing a bra, specifically with the linings and the sideband (figure A and B). Women prefer a more cranial position of the S-ICD generator with the lower sideband supporting the device (figure C). A position of the S-ICD generator posterior from the lining of the left cup also reduces discomfort.

Conclusion: Female S-ICD patients experience a variety of gender-specific issues with a substantial impact on their daily life. Implanters should provide adequate counseling and use bra position during pre-implant marking to minimize daily discomfort of female patients.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are